Jarvik Heart said it won pre-market approval from the Japanese Pharmaceuticals & Medical Devices Agency for its Jarvik 2000 heart, a left ventricular-assist device.
New York-based Jarvik Heart said the device is the smallest LVAD approved for long-term use in Japan.
The Jarvik 2000 is capable of supporting patients as small as 4′ 6″ tall & weighing less than 85 lbs. and as big as 6′ 2″ tall & weighing more than 225 lbs., by utilizing different speeds for the different sizes.
The device already has CE Mark approval in the European Union. Jarvik Heart ran a 150-patient pivotal trial for bridge-to-transplant therapy in the U.S., according to a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.